FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2560083539> ?p ?o ?g. }

• W2560083539 endingPage "196" @default.
• W2560083539 startingPage "190" @default.
• W2560083539 abstract "Though anecdotally linked, few studies have investigated the impact of facial paralysis on depression and quality of life (QOL). To measure the association between depression, QOL, and facial paralysis in patients seeking treatment at a facial plastic surgery clinic. Data were prospectively collected for patients with all-cause facial paralysis and control patients initially presenting to a facial plastic surgery clinic from 2013 to 2015. The control group included a heterogeneous patient population presenting to facial plastic surgery clinic for evaluation. Patients who had prior facial reanimation surgery or missing demographic and psychometric data were excluded from analysis. Demographics, facial paralysis etiology, facial paralysis severity (graded on the House-Brackmann scale), Beck depression inventory, and QOL scores in both groups were examined. Potential confounders, including self-reported attractiveness and mood, were collected and analyzed. Self-reported scores were measured using a 0 to 100 visual analog scale. There was a total of 263 patients (mean age, 48.8 years; 66.9% were female) were analyzed. There were 175 control patients and 88 patients with facial paralysis. Sex distributions were not significantly different between the facial paralysis and control groups. Patients with facial paralysis had significantly higher depression, lower self-reported attractiveness, lower mood, and lower QOL scores. Overall, 37 patients with facial paralysis (42.1%) screened positive for depression, with the greatest likelihood in patients with House-Brackmann grade 3 or greater (odds ratio, 10.8; 95% CI, 5.13-22.75) compared with 13 control patients (8.1%) (P < .001). In multivariate regression, facial paralysis and female sex were significantly associated with higher depression scores (constant, 2.08 [95% CI, 0.77-3.39]; facial paralysis effect, 5.98 [95% CI, 4.38-7.58]; female effect, 1.95 [95% CI, 0.65-3.25]). Facial paralysis was associated with lower QOL scores (constant, 81.62 [95% CI, 78.98-84.25]; facial paralysis effect, −16.06 [95% CI, −20.50 to −11.62]). For treatment-seeking patients, facial paralysis was significantly associated with increased depression and worse QOL scores. In addition, female sex was significantly associated with increased depression scores. Moreover, patients with a greater severity of facial paralysis were more likely to screen positive for depression. Clinicians initially evaluating patients should consider the psychological impact of facial paralysis to optimize care. 2." @default.
• W2560083539 created "2016-12-16" @default.
• W2560083539 creator A5034119908 @default.
• W2560083539 creator A5037284724 @default.
• W2560083539 creator A5039885295 @default.
• W2560083539 creator A5051104127 @default.
• W2560083539 creator A5053204096 @default.
• W2560083539 creator A5058118162 @default.
• W2560083539 date "2017-05-01" @default.
• W2560083539 modified "2023-10-17" @default.
• W2560083539 title "Association Among Facial Paralysis, Depression, and Quality of Life in Facial Plastic Surgery Patients" @default.
• W2560083539 cites W161784625 @default.
• W2560083539 cites W1963935122 @default.
• W2560083539 cites W1969146257 @default.
• W2560083539 cites W1970671402 @default.
• W2560083539 cites W1970703511 @default.
• W2560083539 cites W1972801652 @default.
• W2560083539 cites W1980996468 @default.
• W2560083539 cites W1985687068 @default.
• W2560083539 cites W2018202930 @default.
• W2560083539 cites W2018621407 @default.
• W2560083539 cites W2032665913 @default.
• W2560083539 cites W2037397374 @default.
• W2560083539 cites W2042972472 @default.
• W2560083539 cites W2046186483 @default.
• W2560083539 cites W2052853158 @default.
• W2560083539 cites W2053202495 @default.
• W2560083539 cites W2054293630 @default.
• W2560083539 cites W2054856895 @default.
• W2560083539 cites W2058355492 @default.
• W2560083539 cites W2065443874 @default.
• W2560083539 cites W2067495470 @default.
• W2560083539 cites W2072177902 @default.
• W2560083539 cites W2073558672 @default.
• W2560083539 cites W2084749448 @default.
• W2560083539 cites W2094096650 @default.
• W2560083539 cites W2094232837 @default.
• W2560083539 cites W2106299619 @default.
• W2560083539 cites W2115123100 @default.
• W2560083539 cites W2127932965 @default.
• W2560083539 cites W2133574018 @default.
• W2560083539 cites W2150644745 @default.
• W2560083539 cites W2170179129 @default.
• W2560083539 cites W2171432146 @default.
• W2560083539 cites W2171762740 @default.
• W2560083539 cites W2183589708 @default.
• W2560083539 cites W2207971469 @default.
• W2560083539 cites W2288619388 @default.
• W2560083539 cites W2737966001 @default.
• W2560083539 cites W2948736745 @default.
• W2560083539 cites W4241431355 @default.
• W2560083539 cites W1626581429 @default.
• W2560083539 doi "https://doi.org/10.1001/jamafacial.2016.1462" @default.
• W2560083539 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5469376" @default.
• W2560083539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27930763" @default.
• W2560083539 hasPublicationYear "2017" @default.
• W2560083539 type Work @default.
• W2560083539 sameAs 2560083539 @default.
• W2560083539 citedByCount "124" @default.
• W2560083539 countsByYear W25600835392017 @default.
• W2560083539 countsByYear W25600835392018 @default.
• W2560083539 countsByYear W25600835392019 @default.
• W2560083539 countsByYear W25600835392020 @default.
• W2560083539 countsByYear W25600835392021 @default.
• W2560083539 countsByYear W25600835392022 @default.
• W2560083539 countsByYear W25600835392023 @default.
• W2560083539 crossrefType "journal-article" @default.
• W2560083539 hasAuthorship W2560083539A5034119908 @default.
• W2560083539 hasAuthorship W2560083539A5037284724 @default.
• W2560083539 hasAuthorship W2560083539A5039885295 @default.
• W2560083539 hasAuthorship W2560083539A5051104127 @default.
• W2560083539 hasAuthorship W2560083539A5053204096 @default.
• W2560083539 hasAuthorship W2560083539A5058118162 @default.
• W2560083539 hasBestOaLocation W25600835392 @default.
• W2560083539 hasConcept C118552586 @default.
• W2560083539 hasConcept C139719470 @default.
• W2560083539 hasConcept C141071460 @default.
• W2560083539 hasConcept C159110408 @default.
• W2560083539 hasConcept C162324750 @default.
• W2560083539 hasConcept C2776867660 @default.
• W2560083539 hasConcept C2778987478 @default.
• W2560083539 hasConcept C2779618896 @default.
• W2560083539 hasConcept C2779631380 @default.
• W2560083539 hasConcept C2779951463 @default.
• W2560083539 hasConcept C2780733359 @default.
• W2560083539 hasConcept C2781019609 @default.
• W2560083539 hasConcept C558461103 @default.
• W2560083539 hasConcept C71924100 @default.
• W2560083539 hasConceptScore W2560083539C118552586 @default.
• W2560083539 hasConceptScore W2560083539C139719470 @default.
• W2560083539 hasConceptScore W2560083539C141071460 @default.
• W2560083539 hasConceptScore W2560083539C159110408 @default.
• W2560083539 hasConceptScore W2560083539C162324750 @default.
• W2560083539 hasConceptScore W2560083539C2776867660 @default.
• W2560083539 hasConceptScore W2560083539C2778987478 @default.
• W2560083539 hasConceptScore W2560083539C2779618896 @default.
• W2560083539 hasConceptScore W2560083539C2779631380 @default.
• W2560083539 hasConceptScore W2560083539C2779951463 @default.

• next